Healthcare Value Capital’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Healthcare Value Capital’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$556K	Sell	444 -56	-11%	-$109K	1.1%	21
2021 Q2	$1.58M	Buy	500 +56	+13%	+$222K	3.15%	14
2021 Q1	$2.74M	Sell	444 -112	-20%	-$812K	6.1%	5
2020 Q4	$3.16M	Buy	556 +56	+11%	+$352K	10.65%	3
2020 Q3	$2.99M	Buy	500 +28	+6%	+$163K	9.85%	5
2020 Q2	$2.94M	Buy	472 +236	+100%	+$1.6M	7.51%	4
2020 Q1	$2.28M	Buy	+236	New	+$3.7M	3.83%	15

Other funds holding YARW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Healthcare Value Capital's YARW Position: Q3 2021 in Review

Healthcare Value Capital reduced its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 11% in Q3 2021, selling an estimated $109K and leaving 444 shares worth $556K. The position accounts for 1.1% of the portfolio, ranked #21.

Healthcare Value Capital first reported a position in YARW in Q1 2020 and has held it in 7 quarters since. The position peaked at $3.16M in Q4 2020. 58 funds tracked by Wall St. Rank hold YARW as of Q3 2021.

Healthcare Value Capital held 444 shares of Yarrow Bioscience, Inc. Common Stock worth $556K as of Q3 2021.
Healthcare Value Capital sold 56 Yarrow Bioscience, Inc. Common Stock shares in Q3 2021, an estimated $109K.
Yarrow Bioscience, Inc. Common Stock made up 1.1% of Healthcare Value Capital's portfolio in Q3 2021, its #21 holding.
Healthcare Value Capital first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and has held it in 7 quarters since.
Healthcare Value Capital's Yarrow Bioscience, Inc. Common Stock position peaked at $3.16M in Q4 2020.
58 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.